{
  "id": "MISSION-500-110-1771349271139",
  "itemType": "standalone",
  "questionType": "selectN",
  "topic": "Pharmacology_Cardiovascular",
  "subtopic": "Atrial Fibrillation with RVR",
  "subject": "Medical-Surgical Nursing",
  "difficulty": 5,
  "question": "The nurse is reviewing the client's electronic health record (EHR) before administering the scheduled 10:00 (1000) medications. Based on the data provided, which findings require the nurse to **withhold** the scheduled metoprolol and notify the healthcare provider immediately? Select all that apply.",
  "tabs": [
    {
      "id": "nursesNote",
      "title": "Nurses' Note",
      "content": "Date: Today, Time: 09:30 (0930)\n\nClient is a 68-year-old male with a history of hypertension and systolic heart failure (HFrEF, EF 30%) admitted from the emergency department (ED) 2 hours ago for worsening dyspnea and palpitations over the last 24 hours. Client reports running out of his prescribed furosemide and lisinopril a week ago, stating he \"had to choose between the medication and groceries this month.\" He appears anxious and restless. Skin is cool to the touch and diaphoretic. Coarse crackles auscultated in bilateral lower lung bases. 2+ pitting edema noted in lower extremities. Urine output via indwelling catheter 40 mL in the last 2 hours."
    },
    {
      "id": "vitalSigns",
      "title": "Vital Signs",
      "content": [
        {
          "time": "08:00 (0800) (ED)",
          "hr": "155",
          "bp": "110/72",
          "rr": "24",
          "spo2": "93% on 2L NC"
        },
        {
          "time": "09:00 (0900) (Unit)",
          "hr": "148",
          "bp": "102/68",
          "rr": "26",
          "spo2": "92% on 2L NC"
        },
        {
          "time": "10:00 (1000) (Current)",
          "hr": "152",
          "bp": "92/60",
          "rr": "28",
          "spo2": "91% on 3L NC"
        }
      ]
    },
    {
      "id": "labResults",
      "title": "Laboratory Results",
      "content": [
        {
          "lab": "Potassium",
          "value": "3.4 mEq/L",
          "range": "3.5-5.0 mEq/L"
        },
        {
          "lab": "BUN",
          "value": "38 mg/dL",
          "range": "10-20 mg/dL"
        },
        {
          "lab": "Creatinine",
          "value": "1.9 mg/dL",
          "range": "0.6-1.2 mg/dL"
        },
        {
          "lab": "Troponin I",
          "value": "0.28 ng/mL",
          "range": "<0.04 ng/mL"
        },
        {
          "lab": "Lactate, Arterial",
          "value": "3.8 mmol/L",
          "range": "0.5-2.2 mmol/L"
        }
      ]
    },
    {
      "id": "diagnostics",
      "title": "Diagnostics",
      "content": "**12-Lead ECG (08:15 (0815)):** Atrial fibrillation with a rapid ventricular response, rate 150-160/min. Non-specific ST and T wave abnormalities.\n\n**Portable Chest X-Ray (09:00 (0900)):** Findings consistent with moderate pulmonary vascular congestion and small bilateral pleural effusions."
    },
    {
      "id": "mar",
      "title": "MAR",
      "content": [
        {
          "medication": "Metoprolol Tartrate 5 mg IV Push",
          "route": "IV",
          "frequency": "STAT, one dose",
          "time": "10:00 (1000)",
          "status": "Due"
        },
        {
          "medication": "Furosemide 40 mg IV Push",
          "route": "IV",
          "frequency": "STAT, one dose",
          "time": "10:00 (1000)",
          "status": "Due"
        }
      ]
    }
  ],
  "options": [
    {
      "id": "opt_4",
      "text": "Serum potassium of 3.4 mEq/L"
    },
    {
      "id": "opt_6",
      "text": "Cool and diaphoretic skin"
    },
    {
      "id": "opt_5",
      "text": "Arterial lactate of 3.8 mmol/L"
    },
    {
      "id": "opt_3",
      "text": "Chest x-ray showing pulmonary congestion"
    },
    {
      "id": "opt_1",
      "text": "Heart rate of 152/min"
    },
    {
      "id": "opt_2",
      "text": "Blood pressure of 92/60 mmHg"
    }
  ],
  "correctAnswer": [
    "opt_2",
    "opt_3",
    "opt_5",
    "opt_6"
  ],
  "scoring": {
    "type": "plus_minus",
    "partialScoring": true
  },
  "answerBreakdown": [
    {
      "optionId": "opt_1",
      "isCorrect": false,
      "rationale": "Incorrect. A heart rate of 152/min in the context of atrial fibrillation with rapid ventricular response (RVR) is elevated, but it's the *indication* for administering metoprolol, a beta-blocker used to slow the heart rate. Withholding metoprolol based solely on the elevated heart rate would be inappropriate. The nurse needs to consider the *cause* of the elevated heart rate and the client's overall clinical picture. The underlying pathophysiology of atrial fibrillation involves disorganized electrical activity in the atria, leading to rapid and irregular ventricular contractions. Metoprolol works by blocking beta-1 adrenergic receptors in the heart, decreasing heart rate and contractility. However, in this case, other factors take precedence.",
      "clinicalPearls": [
        "Consider the underlying cause of tachycardia before administering rate-controlling medications.",
        "Always assess the client's overall hemodynamic status before administering beta-blockers."
      ]
    },
    {
      "optionId": "opt_2",
      "isCorrect": true,
      "rationale": "Correct. A blood pressure of 92/60 mmHg indicates hypotension. Metoprolol, a beta-blocker, has negative inotropic and chronotropic effects, meaning it decreases both the force of heart muscle contraction and the heart rate. Administering metoprolol to a hypotensive client could further reduce cardiac output and lead to or exacerbate cardiogenic shock. In cardiogenic shock, the heart's ability to pump blood effectively is severely compromised, leading to inadequate tissue perfusion. The reduced blood pressure reflects this impaired cardiac output and the body's inability to maintain adequate blood flow to vital organs. This is a critical safety concern.",
      "clinicalPearls": [
        "Hypotension is a contraindication for beta-blocker administration.",
        "Monitor blood pressure closely before and after administering beta-blockers."
      ]
    },
    {
      "optionId": "opt_3",
      "isCorrect": true,
      "rationale": "Correct. Pulmonary congestion, as evidenced by the chest x-ray, indicates fluid overload in the lungs, a hallmark sign of acute decompensated heart failure (ADHF). In ADHF, the heart is unable to pump enough blood to meet the body's needs, leading to a backup of fluid in the pulmonary circulation. This increased pulmonary pressure forces fluid into the alveoli, impairing gas exchange and causing dyspnea. While beta-blockers like metoprolol are sometimes used in chronic heart failure, they are generally contraindicated in the *acute* phase of ADHF, especially when there is evidence of fluid overload. The negative inotropic effects of metoprolol can further reduce cardiac output and worsen pulmonary edema.",
      "clinicalPearls": [
        "Pulmonary congestion is a key indicator of ADHF.",
        "Avoid beta-blockers in the initial management of ADHF with fluid overload."
      ]
    },
    {
      "optionId": "opt_4",
      "isCorrect": false,
      "rationale": "Incorrect. A potassium level of 3.4 mEq/L is slightly below the normal range (3.5-5.0 mEq/L), indicating hypokalemia. While hypokalemia can increase the risk of arrhythmias and should be addressed, it is not an *absolute* contraindication to metoprolol. The more immediate concern is the client's hypotension, pulmonary congestion, elevated lactate, and signs of hypoperfusion, which suggest a progression towards cardiogenic shock. Addressing the hypokalemia is important, but it is not the priority in this critical situation. Hypokalemia affects the resting membrane potential of cardiac cells, making them more susceptible to arrhythmias.",
      "clinicalPearls": [
        "Hypokalemia can increase the risk of arrhythmias.",
        "Address electrolyte imbalances, but prioritize interventions based on the client's immediate needs."
      ]
    },
    {
      "optionId": "opt_5",
      "isCorrect": true,
      "rationale": "Correct. An arterial lactate level of 3.8 mmol/L is elevated (normal range: 0.5-2.2 mmol/L), indicating tissue hypoperfusion and anaerobic metabolism. Lactate is produced when cells don't receive enough oxygen to meet their energy demands, forcing them to switch to anaerobic metabolism. This is a key indicator of shock, where inadequate blood flow leads to oxygen deprivation in tissues. The elevated lactate level confirms that the client's tachycardia is not effectively compensating for the decreased cardiac output, and they are progressing towards circulatory collapse. Administering metoprolol, which further reduces cardiac output, would exacerbate the hypoperfusion and worsen the shock state.",
      "clinicalPearls": [
        "Elevated lactate levels indicate tissue hypoperfusion.",
        "Monitor lactate levels in clients at risk for shock."
      ]
    },
    {
      "optionId": "opt_6",
      "isCorrect": true,
      "rationale": "Correct. Cool, diaphoretic skin is a classic clinical sign of hypoperfusion and sympathetic nervous system activation, characteristic of impending shock. When cardiac output decreases, the body attempts to compensate by activating the sympathetic nervous system, leading to vasoconstriction and increased heart rate. This shunts blood away from the periphery to vital organs, resulting in cool, clammy skin. Diaphoresis (sweating) is another manifestation of sympathetic nervous system activation. This physical assessment finding, combined with the vital signs and lab data, paints a clear picture of hemodynamic instability, making the administration of IV metoprolol unsafe.",
      "clinicalPearls": [
        "Cool, diaphoretic skin is a sign of hypoperfusion.",
        "Assess skin temperature and moisture as part of a comprehensive assessment."
      ]
    }
  ],
  "clientNeed": [
    {
      "category": "Safe and Effective Care Environment",
      "subcategory": "Safety and Infection Control"
    },
    {
      "category": "Physiological Integrity",
      "subcategory": "Pharmacological and Parenteral Therapies"
    }
  ],
  "cognitiveSkill": "Analyze Cues & Take Action",
  "ncsbnClinicalJudgment": "The student must synthesize data from multiple sources (vitals, labs, diagnostics, assessment) to recognize a complex clinical picture of acute decompensated heart failure progressing to cardiogenic shock. The critical action is to identify the contraindication to a standard therapy (IV beta-blocker for RVR) in the context of hemodynamic instability. This requires prioritizing the 'Don't Proceed' safety action over treating the symptomatic tachycardia.",
  "healthEquity": "The scenario includes a Social Determinant of Health (SDOH) cue (medication non-adherence due to cost), which is a contributing factor to the client's acute decompensation. While not directly part of the immediate safety decision, it provides context for the client's condition and highlights the need for comprehensive discharge planning, including social work and case management referrals.",
  "situation": "A 68-year-old male with a history of hypertension and systolic heart failure (HFrEF, EF 30%) was admitted from the emergency department (ED) two hours ago for worsening dyspnea and palpitations over the last 24 hours.",
  "background": "The client reports running out of his prescribed furosemide and lisinopril a week ago, stating he \"had to choose between the medication and groceries this month.\" He has a diagnosis of atrial fibrillation with rapid ventricular response.",
  "assessment": "The client appears anxious and restless. Skin is cool to the touch and diaphoretic. Coarse crackles auscultated in bilateral lower lung bases. 2+ pitting edema noted in lower extremities. Urine output via indwelling catheter 40 mL in the last 2 hours. Current vital signs: HR 152/min, BP 92/60 mmHg, RR 28/min, SpO2 91% on 3L NC. Laboratory results indicate potassium 3.4 mEq/L, BUN 38 mg/dL, creatinine 1.9 mg/dL, troponin I 0.28 ng/mL, and arterial lactate 3.8 mmol/L. Chest x-ray shows pulmonary congestion.",
  "recommendation": "Based on the client's current assessment findings, the nurse should withhold the scheduled metoprolol and immediately notify the healthcare provider due to concerns of acute decompensated heart failure and potential cardiogenic shock.",
  "clinicalPearls": [
    "IV beta-blockers are generally contraindicated in acute decompensated heart failure (ADHF) due to their negative inotropic effects, which can worsen cardiac output and pulmonary edema.",
    "Elevated lactate levels and signs of hypoperfusion (cool, diaphoretic skin) indicate tissue hypoxia and potential progression to shock.",
    "Social determinants of health, such as medication affordability, can significantly impact a client's health status and contribute to acute decompensation."
  ],
  "sentinelStatus": "healed_v2026_v8",
  "sbar": {
    "situation": "The client is a 68-year-old male with HFrEF and atrial fibrillation with RVR, admitted for worsening dyspnea and palpitations. Metoprolol 5mg IV push is due at 1000.",
    "background": "The client ran out of furosemide and lisinopril a week ago due to financial constraints. ECG shows atrial fibrillation with RVR. Chest X-ray reveals pulmonary congestion.",
    "assessment": "At 1000, the client's HR is 152, BP is 92/60, RR is 28, and SpO2 is 91% on 3L NC. He is anxious, restless, diaphoretic, and has crackles in bilateral lower lung bases and 2+ edema. Lactate is 3.8 mmol/L. These findings indicate ADHF and potential cardiogenic shock.",
    "recommendation": "I recommend withholding the metoprolol due to hypotension, pulmonary congestion, and signs of hypoperfusion. I am concerned about potential cardiogenic shock. I request an immediate order to evaluate and manage the client's ADHF and hemodynamic instability. Consider alternative rate control strategies if needed, once the client is stabilized."
  }
}